TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Efficacy of betaine combined with standard antiviral therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of betaine combined with standard antiviral therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Transplantation free survival
Endpoint domain: Mortality/survival
Primary endpoint: Clinical success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maximal isometric muscle strength for knee extensors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean Change in Amblyopic Eye Visual Acuity From Baseline to 24 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in central macular thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in retinal vascular density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in outer retina flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of errors committed
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of ARDS/ALI
Endpoint domain: Adverse events/effects
Primary endpoint: Absence of histologic HSIL (CIN2/3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Assessment of cutaneous toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Cesarean Surgical Site Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline 6 Minute Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline COPD Assessment Test (CAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QT interval on ECG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Coronary plaque burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Coronary plaque morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in endothelial cell density (ECD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Greater Than or Equal to 60% Tumor S6 Kinase Inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Median S6 Kinase Inhibition in Prostate Tumor Tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Median Post-treatment S6 Activity H-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Total Number of Hospitalization and Emergency Room Visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Rate of Torque Development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Time to the Second Stage of Labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Core strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: number of positive tuberculosis culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Subjects With Grade 3 to 5 Toxicity During the Dose Limiting Toxicity (DLT) Period
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects With a Dose Limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Infused Patients With Best Overall Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed plasma concentration of pioglitazone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach the maximum observed plasma concentration of pioglitazone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination half-life associated with the terminal slope of the semilogarithmic drug concentration-time curve of pioglitazone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfactory bowel preparation quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mouth opening measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug Utilization Patterns
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cognitive Subscale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: De Novo Lipogenesis in adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Alveolar Ridge Volumetric Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of lower extremity independence time during 10 min standing bout
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of stepping independence time during 6 min stepping bout
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of number of consecutive hip flexion repetitions performed within one minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in safety relevant parameters
Endpoint domain: Adverse events/effects
Primary endpoint: Quantitative method validation (antibody concentrations)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Radiographic periapical healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone mineral density improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of Subjects Who Experienced Dose Limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Cortisol Concentrations (AUC Over 24 Hours)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: mean steady-state atazanavir trough plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent inhibition to the 60 msec prepulse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total recall score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: change in salivary cotinine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADL (Activity of daily living)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rescue medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Isometric back extensors endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interictal epileptiform activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Penile Length Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appetite hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Markers of colonic fermentation and inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Recurrence at six months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in baseline of Diabetes Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of life for terminally ill cancer patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Psychological well-beings for terminally ill cancer patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Duration of migraine pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of Lean Body Mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change on the Post Concussion Symptom Inventory (PCSI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Geometric Mean Titers of Serum Bovine Albumin Baby Rabbit Titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With Serum Bovine Albumin Baby Rabbit Titers of ≥ 1:8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Fibrinogen Level at 2 Hours After Delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Maximum Expiratory Pressure From Baseline to Extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Maximum Inspiratory Pressure From Baseline to Extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: HPV DNA and HIV Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HPV DNA and Pap Smear Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of HPV Genotypes Isolated by HIV Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Commonest HPV Genotypes Isolated by HIV Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cerebral metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cumulative recovery of total radioactivity in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cumulative recovery of total radioactivity in faeces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Infant cognitive and motor development
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Maternal thyroid function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: mean change in urge incontinence episodes per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: incidence of clinically significant cardiac iron overload
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence Rate of Thromboembolytic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: In-breast tumor recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Diarrheal morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Self-reported alcohol consumption in the prior 28 days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of risky drinking days in the prior 28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate control of asthma symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypoxia related metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: amenorrhea rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Gait differences (kinetic)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait differences (kinematic)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Triceps Surae muscle activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Morphological differences in calf muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reporting of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Length Of Stay (LOS) in the medical ICU
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Medical ICU re-admission during the hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Family satisfaction with care in ICU
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cold test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electrical pulp test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain during the treatment
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Crossing the Target Lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of substance abusers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24 hour Diaper test (weight in grams)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal Serum B12 Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sensitivity of Endoscopic Ultrasound-guided Puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Family Cohesion
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Parent and Child Relationship
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adipose gene expression signatures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: New or worsened lesions on postoperative MRI-scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Charcot Marie Tooth Neuropathy Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Expected number of similar quality scans produced
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of enrolled patients that complete all required scans
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Range of tumor hypoxia in patients with pancreatic cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Overall tumor response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from Baseline Intensity of Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With and Without Non-hazardous Drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With >90% Isoniazid (INH) Adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 24-h number of PVCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Effective rate of 24-h number of PVCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy of oral wheat desensitization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of preparation for sigmoidoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Vocabulary Expressive of the Child
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life of the Child
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Emotional and Behaviour Problems of the Child
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: variation of the delta of G-MISS Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in infant percent body fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety of use
Endpoint domain: Adverse events/effects
Primary endpoint: change of degree of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of Straight leg raising test (SLRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of Femoral stretch test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of Modified Schober's test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: insulin homeostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Venous umbilical cord pH at birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Teacher ratings of academic performance
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Smoking behaviors perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of demands for analgesic
Endpoint domain: Adverse events/effects
Primary endpoint: Timing of first demand for analgesic
Endpoint domain: Adverse events/effects
Primary endpoint: Self-assessed perineal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in albumin excretion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Validity of inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pain during dental anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diameter of induration at injection sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous breathing test (SBT) pass rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous breathing test (SBT) fail rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications related to intrabdominal injury
Endpoint domain: Adverse events/effects
Primary endpoint: time required to habituate a first object
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time required to present a new object
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VLDL-TG turnover
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ever received public disability program benefits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Ever applied for public disability program benefits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: proportion of reported sample size definitions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Presence or absence of obstructive CAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With at Least One Moderate or Severe Asthma Exacerbation Over Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean Change in Asthma Control Over Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Pediatric Asthma Quality of Life Over Time
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PSA-level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients returning consciousness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of severe visual loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardio-respiratory fitness (VO2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Severity of patient-reported symptoms of mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in foot care knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in foot care behaviour
Endpoint domain: Life impact
Endpoint subdomain: Health-related behaviour
Primary endpoint: Foetal glycated hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of Participants Who Experienced Virologic Breakthrough
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Hepatic Transaminase Elevation Requiring Immunosuppression
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Bleeding Events (Spontaneous and Traumatic)
Endpoint domain: Adverse events/effects
Primary endpoint: Venous thromboembolism free survival
Endpoint domain: Mortality/survival
Primary endpoint: VWF Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of rumination
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: UDCA response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Feasibility of at-home use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in M/P40 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of interventions to Treat Retained Blood Syndrome
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of direct cleavage from 1 to 3 and from 2 to 5 cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of uneven blastomeres at the 2 and 4 cell stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of bi- and multinucleation at 2 cell and 4 cell stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Smooth Endoplasmatic Reticulum at various stages
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes